Structural basis for the activation of PLC-γ isozymes by phosphorylation and cancer-associated mutations
Open accessAbstract
Direct activation of the human phospholipase C-γ isozymes (PLC-γ1, -γ2) by tyrosine phosphorylation is fundamental to the control of diverse biological processes, including chemotaxis, platelet aggregation, and adaptive immunity. In turn, aberrant activation of PLC-γ1 and PLC-γ2 is implicated in inflammation, autoimmunity, and cancer. Although structures of isolated domains from PLC-γ isozymes are available, these structures are insufficient to define how release of basal autoinhibition is coupled to phosphorylation-dependent enzyme activation. Here, we describe the first high-resolution structure of a full-length PLC-γ isozyme and use it to underpin a detailed model of their membrane-dependent regulation. Notably, an interlinked set of regulatory domains integrates basal autoinhibition, tyrosine kinase engagement, and additional scaffolding functions with the phosphorylation-dependent, allosteric control of phospholipase activation. The model also explains why mutant forms of the PLC-γ isozymes found in several cancers have a wide spectrum of activities, and highlights how these activities are tuned during disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In AD, the effect of PLCG2 might depend on the stage of neurodegeneration, the gene expression, the enzymatic activity, and the formation of intracellular signaling complexes in microglia.
“In AD, the effect of PLCG2 might depend on the stage of neurodegeneration, the gene expression, the enzymatic activity, and the formation of intracellular signaling complexes in microglia [10, 13–16].”
From PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease (2022) · cites this paper as [14]
The Introduction links a moderately active PLC-γ2 variant to protection from late-onset Alzheimer’s disease, supporting a possible role for enzymatic activity. It also describes PLC-γ domains that scaffold signaling proteins, but neither the Introduction nor the Discussion says that PLCG2’s effect in Alzheimer’s depends on neurodegeneration stage, gene expression, or signaling-complex formation in microglia. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredFollowing phosphorylation of PLCγ1, the critical pTyr residue binds to its cSH2 domain, and this intramolecular interaction is required for repositioning of the regulatory region and release of autoinhibition.
“Following phosphorylation of PLCγ1, the critical pTyr residue in PLCγ1 binds to its cSH2 domain; this intramolecular interaction is required for repositioning of the regulatory region and release of the autoinhibition.”
From Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane (2020) · cites this paper as [47]
The Results (Structure of full-length PLC-γ1; page not provided) describe pTyr783 as an intramolecular ligand for cSH2. The Discussion (page not provided) proposes that this engagement unlatches cSH2 and initiates regulatory-domain rearrangement, but calls that mechanism presumed rather than establishing that the interaction is required for rearrangement and release of autoinhibition. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPLCγ1 shares 52% sequence identity with PLCγ2, and their overall domain organisation is conserved; therefore, homology models are plausible.
“PLCγ1 shares 52% sequence identity with PLCγ2, and their overall domain organisation is conserved; therefore, homology models are plausible.”
From Characterisation of molecular mechanisms for PLCγ2 disease-linked variants (2024) · cites this paper as Hajicek et al., 2019
The Results section, “Structure of full-length PLC-γ1” (page unavailable), describes domains shared by the PLC-γ isozymes. The Materials and methods section, “Homology modeling” (page unavailable), reports building a PLC-γ2 model from a PLC-γ1 template. Our copy does not substantiate the specific figure of 52% sequence identity. (LLM, conf=0.88)
Experimental — accuracy not yet measuredIn inactive PLCγ1, cSH2 and sPH domains contribute to autoinhibition by interacting with the PLC-core, preventing membrane interactions required for access to PI(4,5)P2.
“In the inactive form, two domains within the regulatory region (cSH2 and sPH) directly contribute to autoinhibition by interacting with the PLC-core, preventing membrane interactions required for the access to the PLC substrate, PI(4,5)P2 [47,48].”
From Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane (2020) · cites this paper as [47]
There are currently no structures for the full-length PLCγ2 molecule, but useful information can be inferred from the recently-published crystal and cryo-electron microscopy (cryoEM) structures of the closely related PLCγ1 molecule.
“Conversely, there are currently no structures for the full-length PLCγ2 molecule, but we can infer some useful information from the recently-published crystal and cryo-electron microscopy (cryoEM) structures of the closely related PLCγ1 molecule [83, 84].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [83]
The crystal and cryoEM structures reveal how the catalytic and γSA regions interact, thus maintaining PLCγ in an autoinhibited state.
“The crystal and cryoEM structures reveal how the catalytic and γSA regions interact, thus maintaining PLCγ in an autoinhibited state [83, 84].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169 · see citing works
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771 · see citing works
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Woyach, J. A., Furman, R. R., Liu, T.-M., Ozer, H. G., Zapatka, M., Ruppert, A. S., Xue, L., Li, D. H.-H., Steggerda, S. M., Versele, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400029 · Cited by 1,275 · see citing works
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · see citing works
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,126 · see citing works
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Landau, D. A., Sun, C., Rosebrock, D., Herman, S. E. M., Fein, J., Sivina, M., Underbayev, C., Liu, D., Hoellenriegel, J., Ravichandran, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02329-y · Cited by 176 · see citing works
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Magno, L., Lessard, C. B., Martins, M., Lang, V., Cruz, P., Asi, Y., Katan, M., Bilsland, J., Lashley, T., Chakrabarty, P., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0469-0 · Cited by 143 · cited 2× · see citing works
“…that stabilize active forms of the PLC-g isozymes might bolster immunotherapies (Guittard et al., 2018) or provide promising leads for the treatment of Alzheimer’s disease where a naturally occurring hypermorphic variant of PLC-g2 is linked to protection from this disease (Magno et al., 2019).”
BackgroundWatanabe, D., Hashimoto, S., Ishiai, M., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T., & Tsukada, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103675200 · Cited by 136 · see citing works
Dysfunction of phospholipase Cγ in immune disorders and cancer
Koss, H., Bunney, T. D., Behjati, S., & Katan, M. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.09.004 · Cited by 115 · see citing works
Bunney, T. D., Esposito, D., Mas-Droux, C., Lamber, E., Baxendale, R. W., Martins, M., Cole, A., Svergun, D., Driscoll, P. C., & Katan, M. (2012) · Structure · doi:10.1016/j.str.2012.09.005 · Cited by 88 · see citing works
Isozyme-specific stimulation of phospholipase C-γ2 by Rac GTPases
Piechulek, T., Rehlen, T., Walliser, C., Vatter, P., Moepps, B., & Gierschik, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509396200 · Cited by 80 · see citing works
Characterization of Phospholipase Cγ Enzymes with Gain-of-Function Mutations
Everett, K. L., Bunney, T. D., Yoon, Y., Rodrigues-Lima, F., Harris, R., Driscoll, P. C., Abe, K., Fuchs, H., Hrabé de Angelis, M., Yu, P., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019265 · Cited by 63 · see citing works
Activation of Phospholipase Cγ2 by Tyrosine Phosphorylation
Özdener, F., Dangelmaier, C., Ashby, B., Kunapuli, S. P., & Daniel, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.672 · Cited by 60 · see citing works
Walliser, C., Retlich, M., Harris, R., Everett, K. L., Josephs, M. B., Vatter, P., Esposito, D., Driscoll, P. C., Katan, M., Gierschik, P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803316200 · Cited by 56 · see citing works
Walliser, C., Hermkes, E., Schade, A., Wiese, S., Deinzer, J., Zapatka, M., Désiré, L., Mertens, D., Stilgenbauer, S., & Gierschik, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746842 · Cited by 51 · cited 6× · see citing works
“These results suggest that once active, the mutant forms of PLC-g2 are stabilized at membranes by binding to Rac2.”
BackgroundInfluential
Flagged first, then by citations
Research works printed but not linked: 75
- Adams PD Afonine PV Bunkóczi G Chen VB Davis IW Echols N Headd JJ Hung LW Kapral GJ Grosse-Kunstleve RW McCoy AJ Moriarty NW Oeffner R Read RJ Richardson DC Richardson JS Terwilliger TC Zwart PH 2010 PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallographica Section D Biological Crystallography 66 213 221 10.1107/S0907444909052925 20124702 PMC2815670 · DOI · Paper page
- Ananthanarayanan B Das S Rhee SG Murray D Cho W 2002 Membrane targeting of C2 domains of phospholipase C-δ isoforms Journal of Biological Chemistry 277 3568 3575 10.1074/jbc.M109705200 11706040 · DOI
- Arteaga CL Johnson MD Todderud G Coffey RJ Carpenter G Page DL 1991 Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas PNAS 88 10435 10439 10.1073/pnas.88.23.10435 1683701 PMC52943 · DOI
- Asokan SB Johnson HE Rahman A King SJ Rotty JD Lebedeva IP Haugh JM Bear JE 2014 Mesenchymal chemotaxis requires selective inactivation of myosin II at the leading edge via a noncanonical PLCγ/PKCα pathway Developmental Cell 31 747 760 10.1016/j.devcel.2014.10.024 25482883 PMC4276478 · DOI
- Bae JH Lew ED Yuzawa S Tomé F Lax I Schlessinger J 2009 The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site Cell 138 514 524 10.1016/j.cell.2009.05.028 19665973 PMC4764080 · DOI · Paper page
- Behjati S Tarpey PS Sheldon H Martincorena I Van Loo P Gundem G Wedge DC Ramakrishna M Cooke SL Pillay N Vollan HKM Papaemmanuil E Koss H Bunney TD Hardy C Joseph OR Martin S Mudie L Butler A Teague JW Patil M Steers G Cao Y Gumbs C Ingram D Lazar AJ Little L Mahadeshwar H Protopopov A Al Sannaa GA Seth S Song X Tang J Zhang J Ravi V Torres KE Khatri B Halai D Roxanis I Baumhoer D Tirabosco R Amary MF Boshoff C McDermott U Katan M Stratton MR Futreal PA Flanagan AM Harris A Campbell PJ 2014 Recurrent PTPRB and PLCG1 mutations in angiosarcoma Nature Genetics 46 376 379 10.1038/ng.2921 24633157 PMC4032873 · DOI
- Braiman A Barda-Saad M Sommers CL Samelson LE 2006 Recruitment and activation of PLCγ1 in T cells: a new insight into old domains The EMBO Journal 25 774 784 10.1038/sj.emboj.7600978 16467851 PMC1383559 · DOI
- Burger JA Landau DA Taylor-Weiner A Bozic I Zhang H Sarosiek K Wang L Stewart C Fan J Hoellenriegel J Sivina M Dubuc AM Fraser C Han Y Li S Livak KJ Zou L Wan Y Konoplev S Sougnez C Brown JR Abruzzo LV Carter SL Keating MJ Davids MS Wierda WG Cibulskis K Zenz T Werner L Dal Cin P Kharchencko P Neuberg D Kantarjian H Lander E Gabriel S O'Brien S Letai A Weitz DA Nowak MA Getz G Wu CJ 2016 Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition Nature Communications 7 11589 10.1038/ncomms11589 27199251 PMC4876453 · DOI · Paper page
- Charpentier TH Waldo GL Barrett MO Huang W Zhang Q Harden TK Sondek J 2014 Membrane-induced allosteric control of phospholipase C-β isozymes Journal of Biological Chemistry 289 29545 29557 10.1074/jbc.M114.586784 25193662 PMC4207972 · DOI
- Chen VB Arendall WB Headd JJ Keedy DA Immormino RM Kapral GJ Murray LW Richardson JS Richardson DC 2010 MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallographica Section D Biological Crystallography 66 12 21 10.1107/S0907444909042073 20057044 PMC2803126 · DOI · Paper page
- Choi J Goh G Walradt T Hong BS Bunick CG Chen K Bjornson RD Maman Y Wang T Tordoff J Carlson K Overton JD Liu KJ Lewis JM Devine L Barbarotta L Foss FM Subtil A Vonderheid EC Edelson RL Schatz DG Boggon TJ Girardi M Lifton RP 2015 Genomic landscape of cutaneous T cell lymphoma Nature Genetics 47 1011 1019 10.1038/ng.3356 26192916 PMC4552614 · DOI
- da Silva Almeida AC Abate F Khiabanian H Martinez-Escala E Guitart J Tensen CP Vermeer MH Rabadan R Ferrando A Palomero T 2015 The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome Nature Genetics 47 1465 1470 10.1038/ng.3442 26551667 PMC4878831 · DOI
- de Gorter DJ Beuling EA Kersseboom R Middendorp S van Gils JM Hendriks RW Pals ST Spaargaren M 2007 Bruton's tyrosine kinase and phospholipase Cγ2 mediate chemokine-controlled B cell migration and homing Immunity 26 93 104 10.1016/j.immuni.2006.11.012 17239630 · DOI · Paper page
- de Lange KM Moutsianas L Lee JC Lamb CA Luo Y Kennedy NA Jostins L Rice DL Gutierrez-Achury J Ji SG Heap G Nimmo ER Edwards C Henderson P Mowat C Sanderson J Satsangi J Simmons A Wilson DC Tremelling M Hart A Mathew CG Newman WG Parkes M Lees CW Uhlig H Hawkey C Prescott NJ Ahmad T Mansfield JC Anderson CA Barrett JC 2017 Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease Nature Genetics 49 256 261 10.1038/ng.3760 28067908 PMC5289481 · DOI · Paper page
- DeBell KE Stoica BA Verí MC Di Baldassarre A Miscia S Graham LJ Rellahan BL Ishiai M Kurosaki T Bonvini E 1999 Functional independence and interdependence of the Src homology domains of phospholipase C-γ1 in B-cell receptor signal transduction Molecular and Cellular Biology 19 7388 7398 10.1128/MCB.19.11.7388 10523627 PMC84732 · DOI
- Deng L Velikovsky CA Swaminathan CP Cho S Mariuzza RA 2005 Structural basis for recognition of the T cell adaptor protein SLP-76 by the SH3 domain of phospholipase Cγ1 Journal of Molecular Biology 352 1 10 10.1016/j.jmb.2005.06.072 16061254 PMC2753203 · DOI
- Ellis MV James SR Perisic O Downes CP Williams RL Katan M 1998 Catalytic domain of phosphoinositide-specific phospholipase C (PLC). Mutational analysis of residues within the active site and hydrophobic ridge of PLCδ1 Journal of Biological Chemistry 273 11650 11659 10.1074/jbc.273.19.11650 9565585 · DOI
- Emsley P Lohkamp B Scott WG Cowtan K 2010 Features and development of Coot Acta Crystallographica. Section D, Biological Crystallography 66 486 501 10.1107/S0907444910007493 20383002 PMC2852313 · DOI
- Everett KL Buehler A Bunney TD Margineanu A Baxendale RW Vatter P Retlich M Walliser C Manning HB Neil MA Dunsby C French PM Gierschik P Katan M 2011 Membrane environment exerts an important influence on Rac-mediated activation of phospholipase Cγ2 Molecular and Cellular Biology 31 1240 1251 10.1128/MCB.01408-10 21245382 PMC3067904 · DOI
- Falasca M Logan SK Lehto VP Baccante G Lemmon MA Schlessinger J 1998 Activation of phospholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting The EMBO Journal 17 414 422 10.1093/emboj/17.2.414 9430633 PMC1170392 · DOI
- Gagné SM Tsuda S Li MX Smillie LB Sykes BD 1995 Structures of the troponin C regulatory domains in the apo and calcium-saturated states Nature Structural & Molecular Biology 2 784 789 10.1038/nsb0995-784 7552750 · DOI
- Gbadegesin RA Adeyemo A Webb NJ Greenbaum LA Abeyagunawardena A Thalgahagoda S Kale A Gipson D Srivastava T Lin JJ Chand D Hunley TE Brophy PD Bagga A Sinha A Rheault MN Ghali J Nicholls K Abraham E Janjua HS Omoloja A Barletta GM Cai Y Milford DD O'Brien C Awan A Belostotsky V Smoyer WE Homstad A Hall G Wu G Nagaraj S Wigfall D Foreman J Winn MP Mid-West Pediatric Nephrology Consortium 2015 HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome Journal of the American Society of Nephrology: JASN 26 1701 1710 10.1681/ASN.2014030247 25349203 PMC4483579 · DOI
- Gibson DG Young L Chuang RY Venter JC Hutchison CA Smith HO 2009 Enzymatic assembly of DNA molecules up to several hundred kilobases Nature Methods 6 343 345 10.1038/nmeth.1318 19363495 · DOI
- Gresset A Hicks SN Harden TK Sondek J 2010 Mechanism of phosphorylation-induced activation of phospholipase C-γ isozymes Journal of Biological Chemistry 285 35836 35847 10.1074/jbc.M110.166512 20807769 PMC2975207 · DOI
- Groesch TD Zhou F Mattila S Geahlen RL Post CB 2006 Structural basis for the requirement of two phosphotyrosine residues in signaling mediated by Syk tyrosine kinase Journal of Molecular Biology 356 1222 1236 10.1016/j.jmb.2005.11.095 16410013 · DOI
- Guittard G Dios-Esponera A Palmer DC Akpan I Barr VA Manna A Restifo NP Samelson LE 2018 The Cish SH2 domain is essential for PLC-γ1 regulation in TCR stimulated CD8+ T cells Scientific Reports 8 5336 10.1038/s41598-018-23549-2 29593227 PMC5871872 · DOI
- Hajicek N Charpentier TH Rush JR Harden TK Sondek J 2013 Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes Biochemistry 52 4810 4819 10.1021/bi400433b 23777354 PMC3844103 · DOI
- Harden TK Sondek J 2006 Regulation of phospholipase C isozymes by ras superfamily GTPases Annual Review of Pharmacology and Toxicology 46 355 379 10.1146/annurev.pharmtox.46.120604.141223 16402909 · DOI
- Hicks SN Jezyk MR Gershburg S Seifert JP Harden TK Sondek J 2008 General and versatile autoinhibition of PLC isozymes Molecular Cell 31 383 394 10.1016/j.molcel.2008.06.018 18691970 PMC2702322 · DOI
- Huang W Hicks SN Sondek J Zhang Q 2011 A fluorogenic, small molecule reporter for mammalian phospholipase C isozymes ACS Chemical Biology 6 223 228 10.1021/cb100308n 21158426 PMC3312000 · DOI
- Huang Z Marsiglia WM Basu Roy U Rahimi N Ilghari D Wang H Chen H Gai W Blais S Neubert TA Mansukhani A Traaseth NJ Li X Mohammadi M 2016 Two FGF receptor kinase molecules act in concert to recruit and transphosphorylate phospholipase Cγ Molecular Cell 61 98 110 10.1016/j.molcel.2015.11.010 26687682 PMC4838190 · DOI
- Huang W Wang X Endo-Streeter S Barrett M Waybright J Wohlfeld C Hajicek N Harden TK Sondek J Zhang Q 2018 A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes Journal of Biological Chemistry 293 1728 1735 10.1074/jbc.RA117.000926 29263090 PMC5798302 · DOI
- Humphries LA Dangelmaier C Sommer K Kipp K Kato RM Griffith N Bakman I Turk CW Daniel JL Rawlings DJ 2004 Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cγ Src homology 2-Src homology 3 linker Journal of Biological Chemistry 279 37651 37661 10.1074/jbc.M311985200 15184383 · DOI
- Jones NP Peak J Brader S Eccles SA Katan M 2005 PLCγ1 is essential for early events in integrin signalling required for cell motility Journal of Cell Science 118 2695 2706 10.1242/jcs.02374 15944397 · DOI
- Kadamur G Ross EM 2013 Mammalian phospholipase C Annual Review of Physiology 75 127 154 10.1146/annurev-physiol-030212-183750 23140367 · DOI · Paper page
- Kataoka K Nagata Y Kitanaka A Shiraishi Y Shimamura T Yasunaga J Totoki Y Chiba K Sato-Otsubo A Nagae G Ishii R Muto S Kotani S Watatani Y Takeda J Sanada M Tanaka H Suzuki H Sato Y Shiozawa Y Yoshizato T Yoshida K Makishima H Iwanaga M Ma G Nosaka K Hishizawa M Itonaga H Imaizumi Y Munakata W Ogasawara H Sato T Sasai K Muramoto K Penova M Kawaguchi T Nakamura H Hama N Shide K Kubuki Y Hidaka T Kameda T Nakamaki T Ishiyama K Miyawaki S Yoon SS Tobinai K Miyazaki Y Takaori-Kondo A Matsuda F Takeuchi K Nureki O Aburatani H Watanabe T Shibata T Matsuoka M Miyano S Shimoda K Ogawa S 2015 Integrated molecular analysis of adult T cell leukemia/lymphoma Nature Genetics 47 1304 1315 10.1038/ng.3415 26437031 · DOI
- Kiel MJ Sahasrabuddhe AA Rolland DCM Velusamy T Chung F Schaller M Bailey NG Betz BL Miranda RN Porcu P Byrd JC Medeiros LJ Kunkel SL Bahler DW Lim MS Elenitoba-Johnson KSJ 2015 Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome Nature Communications 6 8470 10.1038/ncomms9470 26415585 PMC4598843 · DOI
- Kim HK Kim JW Zilberstein A Margolis B Kim JG Schlessinger J Rhee SG 1991 PDGF stimulation of inositol phospholipid hydrolysis requires PLC-γ1 phosphorylation on tyrosine residues 783 and 1254 Cell 65 435 441 10.1016/0092-8674(91)90461-7 1708307 · DOI
- Knyazhitsky M Moas E Shaginov E Luria A Braiman A 2012 Vav1 oncogenic mutation inhibits T cell receptor-induced calcium mobilization through inhibition of phospholipase Cγ1 activation Journal of Biological Chemistry 287 19725 19735 10.1074/jbc.M111.309799 22474331 PMC3366006 · DOI
- Law CL Chandran KA Sidorenko SP Clark EA 1996 Phospholipase C-γ1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk Molecular and Cellular Biology 16 1305 1315 10.1128/MCB.16.4.1305 8657103 PMC231114 · DOI
- Lemmon MA Schlessinger J 2010 Cell signaling by receptor tyrosine kinases Cell 141 1117 1134 10.1016/j.cell.2010.06.011 20602996 PMC2914105 · DOI · Paper page
- Lomasney JW Cheng HF Kobayashi M King K 2012 Structural basis for calcium and phosphatidylserine regulation of phospholipase C δ1 Biochemistry 51 2246 2257 10.1021/bi201252f 22385159 PMC3356995 · DOI
- Lyon AM Tesmer VM Dhamsania VD Thal DM Gutierrez J Chowdhury S Suddala KC Northup JK Tesmer JJ 2011 An autoinhibitory helix in the C-terminal region of phospholipase C-β mediates Gαq activation Nature Structural & Molecular Biology 18 999 1005 10.1038/nsmb.2095 21822282 PMC3168981 · DOI
- Maier JA Martinez C Kasavajhala K Wickstrom L Hauser KE Simmerling C 2015 ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB Journal of Chemical Theory and Computation 11 3696 3713 10.1021/acs.jctc.5b00255 26574453 PMC4821407 · DOI
- Minichiello L Calella AM Medina DL Bonhoeffer T Klein R Korte M 2002 Mechanism of TrkB-mediated hippocampal long-term potentiation Neuron 36 121 137 10.1016/S0896-6273(02)00942-X 12367511 · DOI · Paper page
- Mouneimne G Soon L DesMarais V Sidani M Song X Yip SC Ghosh M Eddy R Backer JM Condeelis J 2004 Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation The Journal of Cell Biology 166 697 708 10.1083/jcb.200405156 15337778 PMC2172433 · DOI
- Nakanishi O Shibasaki F Hidaka M Homma Y Takenawa T 1993 Phospholipase C-γ1 associates with viral and cellular src kinases Journal of Biological Chemistry 268 10754 10759 8388373
- Nishibe S Wahl MI Hernández-Sotomayor SM Tonks NK Rhee SG Carpenter G 1990 Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation Science 250 1253 1256 10.1126/science.1700866 1700866 · DOI
- Nishida M Sugimoto K Hara Y Mori E Morii T Kurosaki T Mori Y 2003 Amplification of receptor signalling by Ca2+ entry-mediated translocation and activation of PLCγ2 in B lymphocytes The EMBO Journal 22 4677 4688 10.1093/emboj/cdg457 12970180 PMC212724 · DOI
- Ombrello MJ Remmers EF Sun G Freeman AF Datta S Torabi-Parizi P Subramanian N Bunney TD Baxendale RW Martins MS Romberg N Komarow H Aksentijevich I Kim HS Ho J Cruse G Jung MY Gilfillan AM Metcalfe DD Nelson C O'Brien M Wisch L Stone K Douek DC Gandhi C Wanderer AA Lee H Nelson SF Shianna KV Cirulli ET Goldstein DB Long EO Moir S Meffre E Holland SM Kastner DL Katan M Hoffman HM Milner JD 2012 Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions The New England Journal of Medicine 366 330 338 10.1056/NEJMoa1102140 22236196 PMC3298368 · DOI · Paper page
- Otwinowski Z Minor W 1997 Processing of X-ray diffraction data collected in oscillation mode Methods in Enzymology 276 307 326 27754618
- Parker L Bahat H Appel MY Baum DV Forer R Pillar N Goldberg M Goldman M 2019 Phospholipase C-Gamma 2 activity in familial steroid-sensitive nephrotic syndrome Pediatric Research 85 719 723 10.1038/s41390-018-0259-6 30568185 · DOI
- Peles E Levy RB Or E Ullrich A Yarden Y 1991 Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma The EMBO Journal 10 2077 2086 10.1002/j.1460-2075.1991.tb07739.x 1676673 PMC452891 · DOI
- Peters KG Marie J Wilson E Ives HE Escobedo J Del Rosario M Mirda D Williams LT 1992 Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis Nature 358 678 681 10.1038/358678a0 1379697 · DOI
- Pierce LC Salomon-Ferrer R de Oliveira C Augusto F McCammon JA Walker RC 2012 Routine access to millisecond time scale events with accelerated molecular dynamics Journal of Chemical Theory and Computation 8 2997 3002 10.1021/ct300284c 22984356 PMC3438784 · DOI
- Poulin B Sekiya F Rhee SG 2000 Differential roles of the Src homology 2 domains of phospholipase C-γ1 (PLC-γ1) in platelet-derived growth factor-induced activation of PLC-γ1 in intact cells Journal of Biological Chemistry 275 6411 6416 10.1074/jbc.275.9.6411 10692443 · DOI
- Poulin B Sekiya F Rhee SG 2005 Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-γ1 PNAS 102 4276 4281 10.1073/pnas.0409590102 15764700 PMC555506 · DOI
- Rodriguez R Matsuda M Perisic O Bravo J Paul A Jones NP Light Y Swann K Williams RL Katan M 2001 Tyrosine residues in phospholipase Cγ2 essential for the enzyme function in B-cell signaling Journal of Biological Chemistry 276 47982 47992 10.1074/jbc.M107577200 11606584 · DOI
- Rouquette-Jazdanian AK Sommers CL Kortum RL Morrison DK Samelson LE 2012 LAT-independent Erk activation via Bam32-PLC-γ1-Pak1 complexes: GTPase-independent Pak1 activation Molecular Cell 48 298 312 10.1016/j.molcel.2012.08.011 22981863 PMC3483363 · DOI
- Schaeffer EM Debnath J Yap G McVicar D Liao XC Littman DR Sher A Varmus HE Lenardo MJ Schwartzberg PL 1999 Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity Science 284 638 641 10.1126/science.284.5414.638 10213685 · DOI
- Serrano CJ Graham L DeBell K Rawat R Veri MC Bonvini E Rellahan BL Reischl IG 2005 A new tyrosine phosphorylation site in PLCγ1: the role of tyrosine 775 in immune receptor signaling The Journal of Immunology 174 6233 6237 10.4049/jimmunol.174.10.6233 15879121 · DOI
- Sherman E Barr VA Merrill RK Regan CK Sommers CL Samelson LE 2016 Hierarchical nanostructure and synergy of multimolecular signalling complexes Nature Communications 7 12161 10.1038/ncomms12161 27396911 PMC4942584 · DOI
- Stols L Gu M Dieckman L Raffen R Collart FR Donnelly MI 2002 A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site Protein Expression and Purification 25 8 15 10.1006/prep.2001.1603 12071693 · DOI
- Takahashi T Yamaguchi S Chida K Shibuya M 2001 A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells The EMBO Journal 20 2768 2778 10.1093/emboj/20.11.2768 11387210 PMC125481 · DOI
- Terwilliger TC Grosse-Kunstleve RW Afonine PV Moriarty NW Zwart PH Hung LW Read RJ Adams PD 2008 Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard Acta Crystallographica Section D Biological Crystallography 64 61 69 10.1107/S090744490705024X 18094468 PMC2394820 · DOI · Paper page
- Timsah Z Ahmed Z Lin CC Melo FA Stagg LJ Leonard PG Jeyabal P Berrout J O'Neil RG Bogdanov M Ladbury JE 2014 Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion Nature Structural & Molecular Biology 21 180 188 10.1038/nsmb.2752 24440983 · DOI
- Tvorogov D Carpenter G 2002 EGF-dependent association of phospholipase C-γ1 with c-Cbl Experimental Cell Research 277 86 94 10.1006/excr.2002.5545 12061819 · DOI
- Vaqué JP Gómez-López G Monsálvez V Varela I Martínez N Pérez C Domínguez O Graña O Rodríguez-Peralto JL Rodríguez-Pinilla SM González-Vela C Rubio-Camarillo M Martín-Sánchez E Pisano DG Papadavid E Papadaki T Requena L García-Marco JA Méndez M Provencio M Hospital M Suárez-Massa D Postigo C San Segundo D López-Hoyos M Ortiz-Romero PL Piris MA Sánchez-Beato M 2014 PLCG1 mutations in cutaneous T-cell lymphomas Blood 123 2034 2043 10.1182/blood-2013-05-504308 24497536 · DOI · Paper page
- Vetter ML Martin-Zanca D Parada LF Bishop JM Kaplan DR 1991 Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-γ1 by a kinase activity associated with the product of the trk protooncogene PNAS 88 5650 5654 10.1073/pnas.88.13.5650 1712104 PMC51935 · DOI
- Wahl MI Nishibe S Suh PG Rhee SG Carpenter G 1989 Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium PNAS 86 1568 1572 10.1073/pnas.86.5.1568 2466293 PMC286739 · DOI
- Waldo GL Ricks TK Hicks SN Cheever ML Kawano T Tsuboi K Wang X Montell C Kozasa T Sondek J Harden TK 2010 Kinetic scaffolding mediated by a phospholipase C-β and Gq signaling complex Science 330 974 980 10.1126/science.1193438 20966218 PMC3046049 · DOI
- Wang J Sohn H Sun G Milner JD Pierce SK 2014 The autoinhibitory C-terminal SH2 domain of phospholipase C-γ2 stabilizes B cell receptor signalosome assembly Science Signaling 7 ra89 10.1126/scisignal.2005392 25227611 PMC4180509 · DOI · Paper page
- Yang YR Choi JH Chang JS Kwon HM Jang HJ Ryu SH Suh PG 2012 Diverse cellular and physiological roles of phospholipase C-γ1 Advances in Biological Regulation 52 138 151 10.1016/j.advenzreg.2011.09.017 21964416 · DOI
- Zhou Q Lee GS Brady J Datta S Katan M Sheikh A Martins MS Bunney TD Santich BH Moir S Kuhns DB Long Priel DA Ombrello A Stone D Ombrello MJ Khan J Milner JD Kastner DL Aksentijevich I 2012 A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency The American Journal of Human Genetics 91 713 720 10.1016/j.ajhg.2012.08.006 23000145 PMC3484656 · DOI · Paper page
- Zimmermann L Stephens A Nam SZ Rau D Kübler J Lozajic M Gabler F Söding J Lupas AN Alva V 2018 A completely reimplemented MPI bioinformatics toolkit with a new HHpred server at its core Journal of Molecular Biology 430 2237 2243 10.1016/j.jmb.2017.12.007 29258817 · DOI · Paper page
Cited by
Sorted by citations
Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane
Katan, M., & Cockcroft, S. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200041 · Cited by 176 · see citing works
Tsai, A. P., Dong, C., Lin, P. B.-C., Messenger, E. J., Casali, B. T., Moutinho, M., Liu, Y., Oblak, A. L., Lamb, B. T., Landreth, G. E., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01022-0 · Cited by 92 · see citing works
Tsai, A. P., Dong, C., Lin, P. B.-C., Oblak, A. L., Viana Di Prisco, G., Wang, N., Hajicek, N., Carr, A. J., Lendy, E. K., Hahn, O., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.08.008 · Cited by 71 · see citing works
Self-citationMagno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64 · see citing works
Martín-Nalda, A., Fortuny, C., Rey, L., Bunney, T. D., Alsina, L., Esteve-Solé, A., Bull, D., Anton, M. C., Basagaña, M., Casals, F., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00794-7 · Cited by 56 · see citing works
Le Huray, K. I. P., Bunney, T. D., Pinotsis, N., Kalli, A. C., & Katan, M. (2022) · Science Advances · doi:10.1126/sciadv.abp9688 · Cited by 21 · see citing works
Characterisation of molecular mechanisms for PLCγ2 disease-linked variants
Bunney, T. D., Kampyli, C., Gregory, A., & Katan, M. (2024) · Advances in Biological Regulation · doi:10.1016/j.jbior.2024.101053 · Cited by 8 · see citing works
Shin, Y.-C., Plummer-Medeiros, A. M., Mungenast, A., Choi, H.-W., TenDyke, K., Zhu, X., Shepard, J., Sanders, K., Zhuang, N., Hu, L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6037 · Cited by 7 · see citing works
Ruíz Moleón, V., Fotouhi, M., Alende, C., Ayoubi, R., Bedford, L. M., Southern, K., Richardson, T. I., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF consortium (2024) · F1000Research · doi:10.12688/f1000research.146156.1 · Cited by 1 · see citing works
- Authors
- Hajicek, N., Keith, N. C., Siraliev-Perez, E., Temple, B. R., Huang, W., Zhang, Q., Harden, T. K., & Sondek, J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Sondek, John
- ORCID
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2019-12-31
- Volume
- 8
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC7004563
- OpenAlex
- W4252787894
- Cited by
- 89
- References
- 15
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 18 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 7 · 2019: 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01-GM057391, R01-GM098894)
- National Science Foundation (DGE-1650116)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- phospholipase C-gamma, PLCγ1, PLCγ2, tyrosine phosphorylation, enzyme activation, allosteric regulation, cancer-associated mutations, full-length protein structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review